4978.T

ReproCELL Incorporated [4978.T] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

4978.T Stock Summary

Top 10 Correlated ETFs

4978.T

Top 10 Correlated Stocks

4978.T

In the News

4978.T Financial details

Company Rating
-
Market Cap
13.07B
Income
-217.49M
Revenue
2.51B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
92
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-46.4
Forward P/E
-
PEG
7.01
P/S
5.77
P/B
1.88
P/C
-
P/FCF
-
Quick Ratio
8.78
Current Ratio
9.33
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-2.56
EPS next Y
-
EPS next Q
-
EPS this Y
-52.18%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-16.26%
Revenue last 5Y
22.09%
Revenue Q/Q
6.58%
EPS Q/Q
15.38%
-
-
-
-
SMA20
-10%
SMA50
-28.81%
SMA100
-25%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-4%
ROC
-0.07%
Gross Margin
40%
Oper. Margin
-20%
Profit Margin
-12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
142.0-329.0
52W High
-59.88%
52W Low
-7.04%
RSI
32
Rel Volume
7.46
Avg Volume
578.68K
Volume
4.32M
Perf Week
4.76%
Perf Month
-20.48%
Perf Quarter
-4.35%
Perf Half Y
-5.71%
-
-
-
-
Beta
0.35
-
-
Volatility
3.99%, 10.84%
Prev Close
10%
Price
132
Change
8.2%

Something similar

Top by Market Cap
TL0.DE
GOOG
VFINX
META
EMBASSY.NS
Top Correlated ETFs
XCS3.DE
IQQ4.DE
VIXL.MI
AYEP.DE
BRIC.AS
Top Correlated Stocks
1887.T
4523.T
4579.T
9837.T
7383.T
Similar Market Cap
IFC-PE.TO
CML.JO
GPS
MUNJALAU.NS
ATR

Company Profile

Healthcare Biotechnology
  • Volume Average 578.68K
  • Market Capitalization 13.07B
  • Employee 92
  • CEO Dr. Shuji Yokoyama Ph.D.
  • Headquarters Yokohama,JP
  • IPO Date 2013-06-26
  • Website https://www.reprocell.com

ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.